south congress semaglutide weight loss Shots Weight Loss Program | Personalized

- ITT shows 56 events on semaglutide vs 83 on tirzepatide, HR 0.71, P = 0.046

As the GLP-1 patients in Al-Alys study were all veterans, with full drug coverage, their retention rate was higherroughly 70% after a year

Johanna Olson-Kennedy Person None

retatrutide research uk What TRIUMPH Is Designed to Prove The TRIUMPH programme is structured to evaluate retatrutide across multiple real-world metabolic and obesity-linked conditions, including: Obesity and overweight management in broad populations Cardiometabolic risk and high-risk cohorts Obesity-linked complications , including mechanical and inflammatory outcomes Functional endpoints like mobility and pain reduction (where relevant) Longer-term tolerability at higher investigational doses This matters because weight loss alone is not the only research targetretatrutides triple-agonist profile suggests downstream effects on: energy expenditure pathways hepatic lipid handling adipokine signalling glucose regulation inflammation-associated comorbidity pathways